Twist Bioscience Corporation (TWST) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
August 6, 2021 7:35 AM EDT-- Revenue Growth of 65% over Fiscal 2020 Third Quarter --
-- Order Growth of 58% Year over Year --
-- Gross Margin of 40% for the Quarter --
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the third quarter of fiscal 2021 ended June 30, 2021.
It is an exciting time to be at the... More



